Adapthealth Corp. (AHCO) Stock Price & Analysis
Adapthealth Corp. (AHCO) rose 1.66% to USD 9.81 as of June 10, 2026 at 02:21 UTC, according to Nexqual real-time market data.
AHCO last closed at USD 9.65; the session ranged USD 9.67–9.92 on volume of 881,237 shares. Market capitalization is $1.33B, with a 52-week range of USD 8.06–13.43 (NCM). Source: Nexqual, June 10, 2026 at 02:21 UTC.
Key Statistics (as of June 10, 2026 at 02:21 UTC)
| Price | USD 9.81 |
|---|---|
| Change | ▲ 1.66% (up) |
| Previous Close | USD 9.65 |
| Open | USD 9.68 |
| Day Range | USD 9.67 – 9.92 |
| 52-Week Range | USD 8.06 – 13.43 |
| Volume | 881,237 shares |
| Market Cap | $1.33B |
| Exchange | NCM |
Technical Analysis (AHCO)
Nexqual's technical model rates AHCO "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.87 (oversold) |
| vs SMA50 | Below (USD 11.51) |
| MACD | -0.5 (negative) |
Analyst Ratings (AHCO)
Wall Street analysts rate AHCO "Buy" based on 8 analysts, with a mean price target of USD 14 (range USD 11–18), per Nexqual as of June 10, 2026 at 02:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 14 |
| High Target | USD 18 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 6 / 2 / 0 |
Earnings (AHCO)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $848.59M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.05 vs est 0.01 ▼ miss |
| 2025-12-31 | USD 0.27 vs est 0.34 ▼ miss |
| 2025-09-30 | USD 0.23 vs est 0.24 ▼ miss |
| 2025-06-30 | USD 0.07 vs est 0.16 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financials & Fundamentals (AHCO)
| Total Revenue | $3.29B |
|---|---|
| Revenue Growth (YoY) | +5.40% |
| Gross Margin | +20.40% |
| Operating Margin | +0.67% |
| Profit Margin | -2.42% |
| ROE | -4.85% |
| Debt / Equity | 132.11 |
| Current Ratio | 0.93 |
| Total Cash | $47.96M |
| Total Debt | $2.00B |
| Free Cash Flow | $267.90M |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financial Health Score (AHCO)
Nexqual rates Adapthealth Corp.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:21 UTC.
| Growth | Weak — Revenue -0% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 20%, operating 1% |
| Balance Sheet | Weak — $48M cash vs $2.00B debt |
| Cash Flow | Solid — FCF $268M, 8% margin |
| Efficiency | Critical — ROE -5%, ROA 2.6% |
Ownership (AHCO)
| Insider Ownership | +8.06% |
|---|---|
| Institutional Ownership | +106.72% |
| Shares Outstanding | 136.05M |
| Float | 85.69M |
| Short % of Float | +7.32% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Leadership (AHCO)
Adapthealth Corp. is led by Suzanne M. Foster M.P.H. (age 55), CEO & Director, per Nexqual as of June 10, 2026 at 02:21 UTC.
| CEO & Director | Suzanne M. Foster M.P.H. (age 55) |
|---|---|
| Chief Financial Officer | Jason A. Clemens C.F.A. (age 46) |
| CTO & Chief Innovation Officer | Albert A. Prast (age 65) |
Major Backers & Investors (AHCO)
Notable institutional backers of Adapthealth Corp. include OEP Capital Advisors, LP, Deerfield Management Company, L.P, Reinhart Partners, LLC, according to Nexqual as of June 10, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| OEP Capital Advisors, LP | 11.99% |
| Deerfield Management Company, L.P | 8.44% |
| Reinhart Partners, LLC | 7.41% |
| Skyknight Capital, L.p. | 6.31% |
| FMR, LLC | 5.92% |
| Fidelity | 3.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 18.31% |
| Vanguard Group | 13.8% |
| Dimensional Fund Advisors | 5.09% |
| State Street | 3.16% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
From Adapthealth Corp.'s Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- In addition, AdaptHealth competes with non-HME providers, including CVS and Amazon.
- Numerous federal and state laws and regulations, including HIPAA and the Health Information Technology for Economic and Clinical Health Act ("HITECH Act"), govern the collection, dissemination, security, use and confidentiality of protected health information and other personal information.
- Department of Health and Human Services to revise regulations governing state-directed payment arrangements ("SDPs") to cap total payment rates paid by Medicaid managed care organizations for specified services, including hospital services, by tying caps to Medicare payment rates instead of average commercial rates and imposing lower caps in Expansion States.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPCH | Option Care Health, Inc. | USD 21.11 | ▲ 2.93% |
| ADUS | Addus HomeCare Corporation | USD 92.7 | ▲ 0.65% |
| LPRO | Open Lending Corporation | USD 2.1 | ▼ 0.47% |
| RPAY | Repay Holdings Corporation | USD 3.43 | ▼ 1.15% |
| SIBN | SI-BONE, Inc. | USD 15.53 | ▲ 2.71% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:21 UTC. This page is informational and not investment advice.